Oral bacteriophages and their potential as adjunctive treatments for periodontitis: a narrative review
Journal of Oral Microbiology · 31.12.2025 · 17 (1)
DOI: 10.1080/20002297.2025.2469890 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Oral Microbiology, online erschienen am 25.02.2025. Verfasst von Mwila Kabwe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rural Clinical Sciences, La Trobe Rural Health School & La Trobe Institute for Molecular Science, La Trobe University, Bendigo, Victori…. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
There is no specific cure for periodontitis and treatment is symptomatic, primarily by physical removal of the subgingival plaque biofilm. Current non-surgical periodontal therapy becomes less effective as the periodontal pocket depth increases and as such new adjunctive treatments are required. The development of antibiotic resistance has driven a recent resurgence of interest in bacteriophage therapy.
Methods
Here we review the published literature with a focus on the subgingival phageome, key oral pathobionts and the dysbiotic nature of periodontitis leading to the emergence of synergistic, proteolytic and inflammophilic bacterial species in subgingival plaque. We discuss the opportunities available, the barriers and the steps needed to develop bacteriophage therapy as an adjunctive treatment for periodontitis.
Results
The oral phageome (or virome) is diverse, featuring abundant bacteriophage, that could target key subgingival bacteria. Yet to date few bacteriophages have been isolated and characterised from oral bacterial species, although many more have been predicted by genomic analyses. Bacteriophage therapy has yet to be tested against chronic diseases that are caused by dysbiosis of the endogenous microbial communities.
Conclusion
To be effective as an adjunctive treatment for periodontitis, bacteriophage therapy must cause the collapse of the dysbiotic bacterial community, thereby resolving inflammation and enabling the reestablishment of a health-associated mutualistic subgingival bacterial community. The isolation and characterisation of novel oral bacteriophage is an essential first step in this process. The oral phageome is still poorly described and characterised especially with regard to lytic bacteriophage.Bacteriophage therapy has yet to be applied to any chronic human disease caused by microbial dysbiosis.Despite many challenges bacteriophage therapy offers the potential to be a safe, specific and efficacious adjunctive treatment for periodontitis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rural Clinical Sciences, La Trobe Rural Health School & La Trobe Institute for Molecular Science, La Trobe University, Bendigo, Victoria, Australia.
- Melbourne Dental School, University of Melbourne, Parkville, Victoria, Australia.
ORCID-Profile: Stuart Dashper
Zitieren
APA
Kabwe, M., Tucci, J., Darby, I., & Dashper, S. (2025). Oral bacteriophages and their potential as adjunctive treatments for periodontitis: a narrative review. Journal of Oral Microbiology, 17(1). https://doi.org/10.1080/20002297.2025.2469890
Vancouver
Kabwe M, Tucci J, Darby I, Dashper S. Oral bacteriophages and their potential as adjunctive treatments for periodontitis: a narrative review. Journal of Oral Microbiology. 2025;17(1). doi:10.1080/20002297.2025.2469890
BibTeX
@article{Kabwe2025,
author = {Kabwe, Mwila and Tucci, Joseph and Darby, Ivan and Dashper, Stuart},
title = {Oral bacteriophages and their potential as adjunctive treatments for periodontitis: a narrative review},
journal = {Journal of Oral Microbiology},
year = {2025},
volume = {17},
number = {1},
doi = {10.1080/20002297.2025.2469890}
}
EUVIMED